Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 342 participants.

Also called NCT06374823

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 342 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06374823
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06374823. Randomized; no masking; primary purpose treatment. Start 2024-05 (anticipated); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke
Acronym
MERIT
Condition
Critical Care
Condition
Hyperchloremia
Condition
Hemorrhagic Stroke
Intervention (Drug)
Multiple Electrolyte
Intervention (Drug)
Normal Saline
Lead sponsor
Capital Medical University (class: other)

Record details

Record id
cardio:ct-nct06374823
Content hash
a066977a9fbe7adb72acf3ca3f3da0fffcdc9d2a647b4352bdb8779dd1012be7